Diabetic retinopathy (DR), with increasing incidence, is the major cause of vision loss and
blindness worldwide in working-age adults. Diabetic macular edema (DME) remains the …

The blood–retina barrier (BRB) is the term used to define the properties of the retinal
capillaries and the retinal pigment epithelium (RPE), which separate the systemic circulation …

Background To reduce treatment burden and optimise patient outcomes in diabetic macular
oedema, we present 1-year results from two phase 3 trials of faricimab, a novel angiopoietin …

Diabetic retinopathy is a common complication of diabetes and remains the leading cause of
blindness among the working-age population. For decades, diabetic retinopathy was …

Purpose To compare the efficacy and safety of brolucizumab with aflibercept in patients with
diabetic macular edema (DME). Design Double-masked, 100-week, multicenter, active …

The high prevalence of cardiovascular disease particularly in the elderly population is
associated with retinal vascular disease. Retinal vein occlusions represent severe …

Diabetic retinopathy (DR) is the most common microangiopathic complication of diabetes
mellitus, representing a major cause of visual impairment in developed countries …

Purpose To prospectively determine the relationship of OCT angiography (OCTA) metrics to
diabetic retinopathy (DR) progression and development of diabetic macular edema (DME) …

Diabetic retinopathy (DR) is a leading cause of blindness. It has long been regarded as
vascular disease, but work in the past years has shown abnormalities also in the neural …

Vision loss in diabetic retinopathy (DR) is ascribed primarily to retinal vascular abnormalities—
including hyperpermeability, hypoperfusion, and neoangiogenesis—that eventually lead to …